What Is MK-677 (Ibutamoren)?
MK-677, also known as Ibutamoren or Nutrobal, is an orally active, non-peptide ghrelin receptor agonist that has been extensively studied for its ability to stimulate the release of growth hormone (GH) and raise insulin-like growth factor-1 (IGF-1) levels without significantly impacting cortisol. Unlike peptide-based GH secretagogues, MK-677 is active by mouth — making it a uniquely practical compound for laboratory research into the GH/IGF-1 axis.
Researchers studying growth hormone deficiency, muscle-wasting conditions, and sleep quality have turned to MK-677 because of its sustained, dose-dependent effects on GH pulsatility. In clinical research settings, doses between 10–25 mg per day have been studied for periods of several months without significant hormonal disruption beyond the GH axis.
Mechanism of Action
MK-677 mimics the action of the hormone ghrelin, binding to the growth hormone secretagogue receptor (GHSR-1a) in the pituitary and hypothalamus. This binding triggers a downstream cascade that amplifies pulsatile GH release. Because MK-677 does not suppress the natural feedback loop of GH, pulsatile secretion is maintained rather than flattened — a meaningful distinction for physiological research.
The resulting elevation in IGF-1 is well-documented. A landmark study by Nass et al. (2008) demonstrated that MK-677 at 25 mg/day for 2 years produced sustained increases in GH and IGF-1 without tachyphylaxis in healthy older adults, with IGF-1 increases of 40–89% reported across dosing cohorts. [PMID: 18981485] This makes MK-677 a valuable tool for researchers exploring the downstream anabolic and metabolic effects of IGF-1 signaling in both in vitro and animal model settings.
Earlier work by Copinschi et al. (1997) established that MK-677 significantly enhanced slow-wave sleep and REM duration at doses of 25 mg/day in young adults — a finding with direct relevance to sleep architecture research. [PMID: 9349662]
Key Research Areas
- Muscle preservation: Studies in older adults and patients with GH deficiency have examined whether MK-677 can attenuate age-related sarcopenia.
- Bone density: IGF-1 plays a direct role in osteoblast stimulation; MK-677 has been studied for its potential in osteoporosis research models.
- Sleep architecture: Human data show significant improvements in REM sleep duration and quality at low doses. [PMID: 9349662]
- Cognitive function: Some research has investigated the neuroprotective potential of GH/IGF-1 axis stimulation in models of neurodegeneration.
How MK-677 Compares to Related Research Compounds
Researchers often study MK-677 alongside selective androgen receptor modulators (SARMs) to investigate additive or synergistic effects on lean body mass. For example, RAD-140 (Testolone) is frequently paired with MK-677 in preclinical research designs examining anabolic signaling through two distinct pathways — the androgen receptor and the GH/IGF-1 axis. Similarly, LGD-4033 (Ligandrol) and MK-2866 (Ostarine) are common comparators in muscle-wasting study designs that include a GH secretagogue arm.
Available Chemyo MK-677 Research Formulations
Chemyo offers MK-677 in two research-grade formulations. The MK-677 Ibutamoren Solution (25mg/ml – 50ml) provides a convenient liquid format for precise dosing in solution-based assays. For researchers requiring raw powder for custom formulations or analytical work, the Ibutamoren MK-677 Powder (1g) is available at >99% purity, third-party verified.
Both products are induction sealed, batch coded, and come with Certificates of Analysis from accredited independent laboratories. All products are intended for laboratory research use only and are not approved for human consumption.
Important Considerations for Researchers
MK-677 is not approved by the FDA for human use and is classified as an investigational compound. It is banned by WADA. Researchers should note that common observations in animal studies include increased appetite, water retention, and transient elevations in fasting blood glucose — variables that should be controlled for in metabolic study designs. Long-term safety data in humans is limited, and all use should be conducted within authorized research protocols.
